In past columns I have defended the commonly used sleeping pill Ambien.

We all like a good mystery, so we tend to overreact and over-personalize infectious threats that are truly remote.

I think it's time I devoted a column to a phenomenon known as forced substitution.

I never believed it was entirely fair that Eli Lilly was the target of vicious attacks regarding its anti-psychotic drug, Zyprexa.

Last fall, the Centers for Disease Control vaccine advisory panel voted to make the shingles vaccination (which had been approved by the FDA in May 2006) routine for the 50 million Americans over the age of 60.

I have been discussing the Chris Benoit case on cable TV news, along with other talking heads including lawyers, doctors and wrestlers.

When Rezulin was removed from the market several years ago, the top endocrinologist I worked with was quite upset.

Statin drugs have received recognition for stabilizing plaque and for reducing the risk of further cardiac events in patients with known heart disease. I am certainly not the only clinician, therefore, to extrapolate from this the usefulness of these drugs in patients who have never had a heart attack but are definitely at serious risk for one.

For many patients suffering from Irritable Bowel Syndrome (IBS) with severe constipation, Novartis’ Zelnorm was a miracle treatment.

Novartis has a new drug that has just been approved by the FDA.